These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1321 related items for PubMed ID: 26991935

  • 1. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A, Nagai J, Togashi K, Goshima Y, Ohshima T.
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [Abstract] [Full Text] [Related]

  • 2. Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's model mice.
    Togashi K, Hasegawa M, Nagai J, Tonouchi A, Masukawa D, Hensley K, Goshima Y, Ohshima T.
    Genes Cells; 2019 Jan; 24(1):31-40. PubMed ID: 30375127
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N, Beiping H, Dheen ST, Tay SS.
    Neuroscience; 2014 Jul 11; 272():167-79. PubMed ID: 24792712
    [Abstract] [Full Text] [Related]

  • 4. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C, Rösler TW, de Andrade A, Oertel WH, Höglinger GU.
    J Neurochem; 2015 May 11; 133(4):590-7. PubMed ID: 25581060
    [Abstract] [Full Text] [Related]

  • 5. Lanthionine ketimine ester improves outcome in an MPTP-induced mouse model of Parkinson's disease via suppressions of CRMP2 phosphorylation and microglial activation.
    Togashi K, Hasegawa M, Nagai J, Kotaka K, Yazawa A, Takahashi M, Masukawa D, Goshima Y, Hensley K, Ohshima T.
    J Neurol Sci; 2020 Jun 15; 413():116802. PubMed ID: 32244093
    [Abstract] [Full Text] [Related]

  • 6. c-Jun/Bim Upregulation in Dopaminergic Neurons Promotes Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease.
    Hu K, Huang Q, Liu C, Li Y, Liu Y, Wang H, Li M, Ma S.
    Neuroscience; 2019 Feb 10; 399():117-124. PubMed ID: 30590105
    [Abstract] [Full Text] [Related]

  • 7. Loss of Collapsin Response Mediator Protein 4 Attenuates 6-Hydroxydopamine-Induced Impairments in a Mouse Model of Parkinson's Disease.
    Li W, Goshima Y, Ohshima T.
    Neurochem Res; 2020 Oct 10; 45(10):2286-2301. PubMed ID: 32648145
    [Abstract] [Full Text] [Related]

  • 8. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E, Hwang I, Park S, Hong S, Hwang B, Cho Y, Son J, Yu JW.
    Cell Death Differ; 2019 Jan 10; 26(2):213-228. PubMed ID: 29786072
    [Abstract] [Full Text] [Related]

  • 9. ICAM-1 may promote the loss of dopaminergic neurons by regulating inflammation in MPTP-induced Parkinson's disease mouse models.
    Zhang F, Pan L, Lian C, Xu Z, Chen H, Lai W, Liang X, Liu Q, Wu H, Wang Y, Zhang P, Zhang G, Liu Z.
    Brain Res Bull; 2024 Aug 10; 214():110989. PubMed ID: 38825252
    [Abstract] [Full Text] [Related]

  • 10. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
    Ding H, Underwood R, Lavalley N, Yacoubian TA.
    Neuroscience; 2015 Oct 29; 307():73-82. PubMed ID: 26314634
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease.
    Qiao C, Zhang Q, Jiang Q, Zhang T, Chen M, Fan Y, Ding J, Lu M, Hu G.
    J Neuroinflammation; 2018 Jul 02; 15(1):193. PubMed ID: 29966531
    [Abstract] [Full Text] [Related]

  • 12. Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy.
    Hu ZL, Sun T, Lu M, Ding JH, Du RH, Hu G.
    Brain Behav Immun; 2019 Oct 02; 81():509-522. PubMed ID: 31288070
    [Abstract] [Full Text] [Related]

  • 13. Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation-induced cell death.
    Liu TY, Yang XY, Zheng LT, Wang GH, Zhen XC.
    J Neurochem; 2017 Feb 02; 140(4):589-604. PubMed ID: 27889907
    [Abstract] [Full Text] [Related]

  • 14. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L, Peritore C, Ginsberg J, Shih J, Arun S, Donmez G.
    Behav Brain Res; 2015 Mar 15; 281():215-21. PubMed ID: 25541039
    [Abstract] [Full Text] [Related]

  • 15. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Hayley S, Crocker SJ, Smith PD, Shree T, Jackson-Lewis V, Przedborski S, Mount M, Slack R, Anisman H, Park DS.
    J Neurosci; 2004 Feb 25; 24(8):2045-53. PubMed ID: 14985447
    [Abstract] [Full Text] [Related]

  • 16. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
    González H, Contreras F, Prado C, Elgueta D, Franz D, Bernales S, Pacheco R.
    J Immunol; 2013 May 15; 190(10):5048-56. PubMed ID: 23589621
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses.
    Calvello R, Cianciulli A, Nicolardi G, De Nuccio F, Giannotti L, Salvatore R, Porro C, Trotta T, Panaro MA, Lofrumento DD.
    J Neuroimmune Pharmacol; 2017 Jun 15; 12(2):327-339. PubMed ID: 27987058
    [Abstract] [Full Text] [Related]

  • 18. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
    Choi DY, Lee MK, Hong JT.
    Neurobiol Dis; 2013 Jan 15; 49():159-68. PubMed ID: 22922220
    [Abstract] [Full Text] [Related]

  • 19. Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease.
    Thomas B, Banerjee R, Starkova NN, Zhang SF, Calingasan NY, Yang L, Wille E, Lorenzo BJ, Ho DJ, Beal MF, Starkov A.
    Antioxid Redox Signal; 2012 May 01; 16(9):855-68. PubMed ID: 21529244
    [Abstract] [Full Text] [Related]

  • 20. Korean red ginseng suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced inflammation in the substantia nigra and colon.
    Jeon H, Bae CH, Lee Y, Kim HY, Kim S.
    Brain Behav Immun; 2021 May 01; 94():410-423. PubMed ID: 33662500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.